Yale Licenses Potential Anti-HIV Agent To Oncolys BioPharma Of Japan
Fri, 30 Jun 2006 08:00 AM EST
... Yale University today announced that it has concluded a license agreement granting Oncolys BioPharma, Inc. of Tokyo the global exclusive right for clinical and business development of a novel compound for the treatment of HIV. [click link for full article] ...
Related Topics
- Agent Orange
- Chemical Agents
- HIV/AIDS & STDs
- HIV Testing
- HIV Antibody
- Wrinkles
- Travel
- Virus
- Aging Skin
- Ovarian Low Malignant Potential Tumors
- Ovarian Low Malignant Potential Tumor
- Aging
- Perinatal HIV
- Riot Control Agents
- Acquired Immune Deficiency Syndrome
- Healthcare Workers
- Bioterrorism
- Japan
- Antibody Tests
- Cmv

Not Signed In -


